Sapphire Radiosurgery Center

What Sapphire Radiosurgery Center does

Saphir Radiochirurgie (Sapphire Radiosurgery Center) is a private, for-profit healthcare provider operating two specialized CyberKnife radiosurgery centers in Frankfurt and Kiel, Germany. The center delivers non-invasive stereotactic radiosurgery to patients with tumors and functional disorders using a robot-controlled CyberKnife system that continuously tracks tumor motion during treatment and concentrates radiation dose on the target while sparing surrounding healthy tissue. With 21 years of clinical experience, a cumulative base of more than 6,250 patients treated, and 151 scientific publications from its medical team, the center positions itself as a research-active subspecialist in stereotactic radiochirurgie rather than a general radiotherapy provider.

The business runs on a professional-services revenue model in which patients are acquired through physician referrals (a dedicated "Für Ärzte & Zuweiser" portal is maintained) and self-referrals, and the center staff handles cost-coverage negotiations with German statutory and private health insurers for each treatment course. Service offerings include general radiosurgery and a dedicated CyberKnife-based prostate cancer therapy focus area. The company operates from a corporate website (saphir-rc.com), maintains an organic social presence on LinkedIn and Instagram, and runs targeted recruitment advertising (Medical Physicist and MFA postings) for its Frankfurt location. The center currently reports 16 employees across its two sites and indicates no external funding, ownership disclosures, or revenue figures.

Strategic positioning combines a published clinical track record and academic hospital partnerships (UKSH for Kiel and Universitätsmedizin Frankfurt for Frankfurt) with the high capital intensity of CyberKnife equipment, creating barriers to local entry. Revenue, headcount trend, and ownership structures are not disclosed in the available data, limiting outside visibility into financial scale and growth dynamics.

Name

Sapphire Radiosurgery Center

Legal name

Saphir Radiochirurgie

Website

https://saphir-radiochirurgie.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Saphir Radiochirurgie is a private German radiosurgery center operating CyberKnife treatment facilities in Frankfurt and Kiel, delivering non-invasive image-guided stereotactic radiosurgery to tumor and functional disorder patients via physician referrals and university hospital partnerships.

Ownership category

akta.pro rank

Product category

Stereotactic Radiosurgery (Radiation Oncology)

NAICS

Freestanding Ambulatory Surgical and Emergency Centers (621493)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Radiation Oncology (HLAKAFAC)

akta.pro secondary industry

Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)

Keywords

• Stereotactic radiosurgery
• CyberKnife therapy
• Radiation oncology
• Tumor treatment
• Radiosurgery services

Headquarters

HQ city

Frankfurt

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Treatment Services: Revenue generated from providing stereotactic radiosurgery and radiation therapy treatments to patients with tumors and functional disorders. Services include initial consultations, treatment planning, actual treatment delivery, and follow-up care. Cost coverage is coordinated with health insurance providers.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Saphir Radiochirurgie operates specialized radiosurgery centers in Frankfurt and Kiel that deliver non-invasive CyberKnife stereotactic radiosurgery for tumor patients and patients with functional disorders. Treatment combines robot-controlled, highly precise radiation delivery with continuous real-time tumor tracking, supported by 21 years of clinical experience and a complete patient pathway covering initial consultation, cost coverage coordination with health insurers, treatment, and follow-up care.

Product overview

Saphir Radiochirurgie is a specialized radiosurgery center operating two facilities in Frankfurt and Kiel, Germany, offering CyberKnife-based stereotactic radiosurgery as its primary treatment technology. The core offering centers on the CyberKnife robotic radiosurgery system, which provides non-invasive, highly precise tumor treatment with real-time tumor tracking. The center also provides specialized prostate cancer therapy as a treatment focus area, with the team having 21 years of experience and over 6,250 patients treated.

Differentiator

Problem solved

Functional benefit

Products and services

• CyberKnife Therapy (CyberKnife Stereotactic Radiosurgery) Robotic, non-invasive stereotactic radiosurgery that delivers highly precise focused radiation to tumors while continuously tracking and compensating for tumor movement in real time, sparing surrounding healthy tissue. Offered to patients with tumors and functional disorders at Saphir Radiochirurgie's Frankfurt and Kiel centers.
• Radiosurgery (Radiochirurgie) Service Non-invasive tumor treatment delivered using focused radiation beams, positioned by Saphir Radiochirurgie as an innovative therapeutic approach that the team has helped develop and continues to advance. Provided to patients at both Frankfurt and Kiel centers.
• Prostate Therapy (Prostata Therapy) Specialized CyberKnife-based radiosurgery treatment for prostate cancer, operated as a dedicated therapy focus area at Saphir Radiochirurgie's Frankfurt and Kiel centers.

Quantifiable outcome

• 6,250+ patients treated successfully
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• UKSH (Universitätsklinikum Schleswig-Holstein)coreStrategic or Co-development PartnerSaphir Radiochirurgie operates in cooperation with UKSH, the university hospital in Schleswig-Holstein. This partnership provides academic credibility and potential research collaboration opportunities. The Kiel location works particularly closely with this partner institution.
• Universitätsmedizin FrankfurtcoreStrategic or Co-development PartnerCooperation with Universitätsmedizin Frankfurt (University of Frankfurt Medical Center). This partnership supports academic research, provides institutional backing for the Frankfurt location, and enables collaboration in medical research and education alongside treatment services.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Asklepios Kliniken: Major German private hospital group with a broad radiation therapy offering. Competes for the same patient base by offering oncology services within a larger hospital ecosystem.
• Helios Kliniken: Germany's largest private hospital operator with multiple radiation oncology and radiosurgery programs. Represents a scaled incumbent competitor that can deploy CyberKnife/Gamma Knife capacity across many sites with referral reach.
• Universitätsklinikum Heidelberg: German university hospital operating the Heidelberg Ion Beam Therapy Center (HIT) for advanced radiation including protons/heavy ions. Comparable as a high-end academic radiation therapy provider and potential competitor for complex cases.
• Schoen Klinik: German private hospital chain operating specialty centers including oncology. Comparable as a privately operated specialty healthcare provider in Germany, though not a focused radiosurgery play.
• Charité – Universitätsmedizin Berlin: One of Europe's largest university hospitals with a comprehensive radiation oncology department offering stereotactic radiotherapy, brachytherapy, and particle therapy. Direct academic competitor in Germany.
• Universitätsmedizin Mainz (CyberKnife Centrum): University hospital operating one of Germany's established CyberKnife centers. Competes in the same stereotactic radiosurgery market from a public hospital base, with broader radiotherapy portfolio beyond CyberKnife.

Others

• Accuray Incorporated: Manufacturer of the CyberKnife and TomoTherapy systems used by Saphir. Adjacent ecosystem participant as the technology supplier, with strategic influence over hardware/service roadmap and pricing.

Regional players

• MedAustron: Austrian center for ion therapy and advanced radiotherapy. Regional European peer in cutting-edge, non-invasive radiation oncology; addresses overlapping indications but with proton/carbon ion technology rather than CyberKnife.

Direct peers

• Europäisches CyberKnife-Zentrum München: Private CyberKnife treatment center in Munich offering stereotactic radiosurgery for tumors and functional disorders. Closest direct competitor in Germany with identical technology platform, similar patient segments, and parallel private-center operating model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/1439020/admin/dashboard
• Instagraminstagram.com/saphirradiochirurgie

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sapphire Radiosurgery Center